Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
Andrew B. Sharabi, Michael Lim, Theodore L. DeWeese, et al.
The Lancet Oncology (2015) Vol. 16, Iss. 13, pp. e498-e509
Closed Access | Times Cited: 772

Showing 26-50 of 772 citing articles:

PD ‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
Abul Kalam Azad, Su Yin Lim, Zenobia D’Costa, et al.
EMBO Molecular Medicine (2016) Vol. 9, Iss. 2, pp. 167-180
Open Access | Times Cited: 194
Immunotherapy in breast cancer: an overview of current strategies and perspectives
Véronique Debien, Alex De Caluwé, Xiaoxiao Wang, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 191
Immunogenic Cell Death Induction by Ionizing Radiation
Mengqin Zhu, Mengdie Yang, Jiajia Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 177
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel, et al.
Cancer Immunology Research (2017) Vol. 5, Iss. 11, pp. 992-1004
Open Access | Times Cited: 176
B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade
Sangwoo S. Kim, Sarek Shen, Sayuri Miyauchi, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 13, pp. 3345-3359
Open Access | Times Cited: 172
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 168
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
Jun Gong, Thang Q. Le, Erminia Massarelli, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 164
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models
Yao‐Xin Lin, Yi Wang, Jianxun Ding, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 599
Open Access | Times Cited: 164
Bacteria and bacterial derivatives as drug carriers for cancer therapy
Zhenping Cao, Jinyao Liu
Journal of Controlled Release (2020) Vol. 326, pp. 396-407
Closed Access | Times Cited: 140
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Alexandre R. Zlotta, Leslie Ballas, Andrzej Niemierko, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 6, pp. 669-681
Closed Access | Times Cited: 126
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 109
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Zhenyu Lin, Ming Cai, Peng Zhang, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003554-e003554
Open Access | Times Cited: 108
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Yoko Nishiga, Alexandros P. Drainas, Maya Baron, et al.
Nature Cancer (2022) Vol. 3, Iss. 11, pp. 1351-1366
Open Access | Times Cited: 87
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy
Mitchell S. Anscher, Shaily Arora, Chana Weinstock, et al.
JAMA Oncology (2022) Vol. 8, Iss. 2, pp. 232-232
Open Access | Times Cited: 82
Development of therapeutic antibodies for the treatment of diseases
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 77
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
Chi‐Leung Chiang, K.W. Chiu, Kenneth Sik Kwan Chan, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 2, pp. 169-178
Closed Access | Times Cited: 75
Biomaterial‐Based In Situ Cancer Vaccines
Bo Yang, Hua Wang
Advanced Materials (2023) Vol. 36, Iss. 43
Open Access | Times Cited: 51
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
Kaisheng You, Qi Wang, Mohamed Syazwan Osman, et al.
BMEMat (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 23
Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
Yongkui Yu, Fanyu Meng, Xiufeng Wei, et al.
Journal of Thoracic and Cardiovascular Surgery (2024) Vol. 168, Iss. 2, pp. 417-428.e3
Closed Access | Times Cited: 19
Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study
Zhengyang Yang, Jiale Gao, Jianyong Zheng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
New insight in immunotherapy and combine therapy in colorectal cancer
Kai Ji, Hang Jia, Zixuan Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 2
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
D. Daydé, Ichidai Tanaka, Rekha Jain, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 3, pp. 573-573
Open Access | Times Cited: 162
Immunotherapy for Head and Neck Squamous Cell Carcinoma
Jessica Moskovitz, Jennifer Moy, Robert L. Ferris
Current Oncology Reports (2018) Vol. 20, Iss. 2
Open Access | Times Cited: 148

Scroll to top